M .J is a 47 year old white woman with no significant medical history. She presents to the Health Care Clinic for her annual physical examination stating. "This should be quick. I've never been sick a day in my life!" She is 5' 5" and weighs 210 lb. with a body mass index (8MI) of35 and a waist circumference of 36.6 inches. Her review of systems and physical examination are unremarkable except for an elevated blood pressure of 140/85. Her fasting laboratory results include the following: total cholesterol. 246 mg/dl; LDL, 121 mg/dl; HDL, 40 mg/dl: triglvcerides, 160 mg/dl; and blood glucose. 114 mg/dl. She works fulltime at a desk job and admits following no regular exercise routine outside ofhousework. She has a family history oftype 2 diabetes and heart disease.
tors meet the criteria for the "metabolic syndrome" and pose a greater risk than any single factor.
BACKGROUND
Metabolic syndrome is a constellation of multiple metabolic and CVD risk factors, at the center of which is insulin resistance (a state in which muscle, liver, and adipose tissues have reduced sensitivity to insulin) and compensatory hyperinsulinemia. Insulin resistance may be present even in the absence of elevated glucose levels or overt diabetes (Ferrannini, 1991; Reaven, 1988) . Dr. Gerald Reaven, who named this grouping "Syndrome X", highlighted the association between insulin resistance and other abnormalities, including dyslipidemia, hypertension, increased plasminogen activator inhibitor-I, hyperuricemia, and visceral obesity (Reaven, 1995) . More typically called "metabolic syndrome," researchers also have included microalbuminuria (Chen, 2004) in the list.
Metabolic syndrome has been shown to be a strong predictor for CVD and type 2 diabetes (Lakka, 2002) and is associated with a threefold increase in the risks for coronary heart disease, myocardial infarction, and stroke, with the sum of multiple components conferring higher risk than any single component (Isomaa, 2001) . Prevalence of the metabolic syndrome among U.S. citizens is high, with an estimated 24% of adults affected (Ford, 2003; Ford, 2002; Meigs, 2003) .
DIAGNOSIS OF METABOLIC SYNDROME
Until recently, there has been no consensus in regard to the criteria for diagnosis of metabolic syndrome. Within the past decade, both the Third Report of the National Cholesterol Education Program's Adult Treatment Panel (ATP III) and the World Health Organization emphasized the importance of this syndrome by establishing diagnostic criteria (Alberti, 1998; Expert Panel, 200 I) . One of the major differences between these two sets of criteria occurs in the defining level for blood pressure. The ATP III criteria for blood pressure control follow the recommendations of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII) and will be used for this article (Chobanian, 2003) . Despite differences, both sets of criteria have been useful in identifying clients with or at high risk for metabolic syndrome (Hanley, 2003) . The ATP III criteria are presented in Table I . Diagnosis of metabolic syndrome is made when three or more of the risk factors are present.
ASSESSMENT
• Obesity and overweight: Although Ms. J's height and weight place her BMI at 35, well over the criteria for obesity (~30), waist circumference is suggested to be the better marker for abdominal fat content (Anonymous, 1998). Her waist circumfer- (Laws, 1992; Mclaughlin, 2003) .
• Her blood pressure of 140/85 exceeds both the ATP III and the JNC VII criteria.
• A fasting glucose of 114 mgldl exceeds the defining level for the metabolic syndrome and is within the range defined as impaired fasting glucose (;;. 100 mgldl to~125 mg/dl) by the American Diabetes Association (American Diabetes, 2004).
MANAGEMENT OF METABOLIC SYNDROME
Management of metabolic syndrome has two objectives: to reduce the underlying causes (i.e., obesity and physical inactivity) and to treat associated lipid and non-lipid risk factors (Expert Panel, 2001) . By reducing obesity and increasing physical activity levels, many of the associated risks, such as impaired fasting glucose, elevated triglycerides, and elevated blood pressure may be ameliorated, if not controlled entirely.
OBESITY AND OVERWEIGHT
Obesity affects approximately 97 million people in the United States and is the second leading cause of preventable death (Anonymous, 1998) . Overweight and obesity are caused by excessive energy (caloric) intake and decreased energy expenditure in terms of physical activity. When counseling a client in regard to weight, it is important to remember that individual weight changes slowly, over time, and weight loss should be undertaken so that changes in diet and caloric intake can be incorporated for life. Even a small amount of weight loss can significantly reduce CVD risks, especially when physical activity is increased.
DIET
Dietary therapy should be individualized to each client, however, an initial goal of weight loss therapy should be to reduce body weight by approxi- Table 2 ).
The current trend in carbohydrate restricted diets has elicited research into optimal nutrient composition for treating overweight and obesity and metabolic syndrome. Although some hypothesize that a reduction in carbohydrate intake may aid in weight loss and decrease postprandial hyperinsulinemia (Samaha, 2003; Wolever, 2003) , more research is necessary to determine the efficacy and safety of these diets.
The ATP III recommendations are based on many clinical trials, offer some flexibility in the amount of carbohydrates within the diet, and stress that carbohydrates should be derived predominantly from complex carbohydrate sources, including fruits, vegetables, and whole grains (Expert Panel, 200 I) . Clients who are diagnosed with metabolic syndrome should be referred to a registered dietician as part of their therapy.
PHYSICAL ACTIVITY
Of equal importance in the treatment plan is regular physical activity. Although the benefits of exercise are well documented, clients who lead sedentary lives often have trouble beginning and maintaining an exercise program. Walking 10,000 steps per day, regardless of intensity or duration, is a simple and effective means of increasing exercise capacity, decreas-ing blood pressure, and decreasing CYD risks, even in the absence of weight loss or change in waist circumference (Iwane, 2000; Swartz, 2003) . Clients should be instructed to wear an inexpensive pedometer and determine their baseline number of daily steps for a 2 week period. They can then increase the number of steps they walk each week by 500 to 1000 until reaching the goal of 10,000 steps.
Internet resources for starting a walking program include www.Americaonthemove.org and www.Shapeup.org/ I OOOOsteps. htm\.
OTHER THERAPIES
When lifestyle changes do not alter the risk profile, pharmacologic therapy may be warranted for optimizing blood pressure and blood lipid control. Ongoing risk factor evaluation is paramount in this population and the occupational health nurse is well positioned to identify and monitor clients with the metabolic syndrome. 
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